Sanofi-Aventis Australia — Stemetil 5mg tablets

PRA number


Published date

Product description

Stemetil (prochlorperazine maleate) 5mg tablets

AUST R 27564

Stemetil is used to treat nausea, vomiting and dizziness due to various causes, including migraine (severe headache).

Batch number 16N0060
Expiry date 06/2018

What are the defects?

This medicine may have been dispensed with missing blister sheets.

What are the hazards?

Affected packs may not contain the correct number of tablets.

What should consumers do?

If you or someone you provide care for takes Stemetil 5mg tablets, please check the batch number (displayed on the packs and blister sheets) to see if it is affected by this recall.

If you have a pack that has been affected by this issue, return any unused medicine to your pharmacy for a refund. If there are no anomalies with your product, you can choose to continue using it as normal.

If you have any other questions or concerns about this issue, talk to your health professional or contact Sanofi-Aventis Medical Information on 1800 818 806.


Sanofi-Aventis Australia

Where the product was sold


Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category